Screener
AdaptHealth AHCO G&A
G&A at other companies
Other financials
Where this comes from
Reported directly by AdaptHealth in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: AdaptHealth’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030602
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net revenue | $819,799 | $777,882 |
| Costs and expenses: | ||
| Cost of net revenue | 708,298 | 657,444 |
| General and administrative expenses | 95,908 | 86,854 |
| Depreciation and amortization, excluding patient equipment depreciation | 10,104 | 10,414 |
| Total costs and expenses | 814,310 | 754,712 |
| Operating income | 5,489 | 23,170 |
| Interest expense, net | 25,594 | 28,399 |
Item 1. Interim Consolidated Financial Statements (Unaudited)
FAQ
- What is AdaptHealth's G&A?
- AdaptHealth (AHCO) reported G&A of $95.91M in Q1 2026.
- How has AdaptHealth's G&A changed year-over-year?
- AdaptHealth's G&A increased by 10.4% year-over-year, from $86.85M to $95.91M.
- What is the long-term trend for AdaptHealth's G&A?
- Over 4 years (2021 to 2025), AdaptHealth's G&A has grown at a 22.9% compound annual growth rate (CAGR), from $167.51M to $382.29M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about AdaptHealth's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude